A Pathway to Better Health: How Supply Chains Deliver on the Promise of GLP-1 Drugs

Life Sciences, Clinical Trials, Pharma Manufacturing & Supply Chain,
  • Friday, May 31, 2024

Discover an insightful webinar exploring the surge in demand for glucagon-like peptide-1 (GLP-1) receptor agonist drugs and learn about the booming market, fueled by the expanding applications and rising popularity of these therapies.

The webinar addresses key issues for bridging the gap to access such as support for personalized approaches tailored to individual needs and optimization to meet soaring demand. The expert speakers will discuss novel supply chain solutions for GLP-1 drugs. Going beyond GLP-1 care and transport, the speakers will talk about innovative temperature-controlled packaging, real-time visibility and advanced tracking systems. They will explore the challenges of balancing clinical trials with patient needs and how next-generation supply chain capabilities and digitalization empower large-scale trials for broader applications.

In this webinar, they will also discuss key challenges such as bridging consumer access gaps, overcoming distribution hurdles and implementing cold chain solutions to manage the costs and complexities of GLP-1 therapies. They will also discuss strategic approaches and innovative solutions, such as employing digital tools to streamline trials and adopting sustainable practices to enhance storage, distribution and overall supply chain efficiency for GLP-1 drugs.

This webinar is ideal for anyone interested in the future of GLP-1 drugs, including Researchers, Clinicians, pharmaceutical professionals and healthcare stakeholders.

Register for this webinar today to gain a better understanding of the evolution of GLP-1 drugs and their supply chains.


Dan Bell_Marken

Dan Bell, SVP Innovation & Strategic Operations, Marken

Dan Bell joined Marken in 2003 and is Senior Vice President of Innovation & Strategic Operations. Dan is a licensed US Customs Broker and a Certified Customs Specialist with over 25 years of experience in the life science logistics and temperature control field. His current focus is regulatory and trade compliance aspects for global life science supply chain solutions.

Dan has served as a liaison between his clients, customs and the alphabet soup of regulatory agencies to ensure the maximum level of compliance with trade laws and regulations. His knowledge and experience in this arena have led to the development of many import strategies that have significantly reduced turnaround times, optimized cost and ensured mission critical objectives have been met or exceeded.

As regulatory scrutiny continues to focus on the temperature-controlled supply chain, Dan’s expertise with thermoregulating packaging solutions and temperature logging devices has been critical to meeting the requirements of the recently updated Good Distribution Practices for pharmaceutical transport and similar guidelines.

Message Presenter
Clay Alexander, Ember Life Sciences

Clay Alexander, Founder and CEO, Ember Life Sciences

Clay Alexander is an American inventor and serial entrepreneur who holds an impressive portfolio of more than 250 patents worldwide and is the founder and chairman of Ember, a global consumer electronics brand best known for the Ember Mug, Ember Baby Bottle, and Ember Cube, all three of which independently have been named TIME Magazine’s Best Inventions of the year. After decades of building and scaling many successful companies, Alexander turned his attention to the area of temperature control. What started as a personal challenge to “keep breakfast warm” has transformed into one of the fastest-growing companies in the world. Ember is currently in over 4,500 retail locations across 27 countries.

In February of 2022, Ember announced the launch of its thermo-electric refrigeration technology to be used to disrupt the cold chain for the healthcare industry. Alexander and his team created the Ember Cube, the world’s first self-refrigerated, cloud-based shipping box.  Alexander’s vision for Ember extends well beyond its current foothold in the consumer electronics market.

Message Presenter

Who Should Attend?

This webinar will appeal to senior professionals who are involved with:

  • Pharmaceutical development
  • Biotechnology companies
  • Central labs
  • Contract manufacturing organizations
  • Contract research organizations
  • CDMOs

What You Will Learn

In this webinar, participants will learn about:

  • Revolutionizing care and transport with thermo-regulated packaging, real-time visibility, tracking and advanced security
  • Personalized approaches for delivering GLP-1 drugs and tailoring the supply chain to individual patient needs
  • Cold chain solutions and strategies for a streamlined value chain to mitigate the rising costs and complexity of developing GLP-1 drugs
  • Partnerships for supporting the timely and secure delivery and transport of critical materials for quality, expedited clinical trials

Xtalks Partner


Marken is the clinical precision logistics and advanced therapy subsidiary of UPS Healthcare. The UPS Healthcare network consists of 200+ locations worldwide. Offering a GMP-compliant depot network in 49 locations, Marken leads in Direct-to-Patient services, biological sample shipments, and kit production. Their 2,600+ staff manage 200,000 monthly shipments in 220+ countries and have arranged 17,000+ home healthcare visits. Services like cell and gene supply chain, ancillary material sourcing, shipment lane verification, and GDP consultancy solidify Marken’s unique position in the industry.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account